BDNF Levels and Neuroplasticity in Mood Disorders

Summary

Brain-derived neurotrophic factor (BDNF) plays a central role in modulating neuroplasticity, the capacity of neuronal networks to adapt structurally and functionally in response to experience. In mood disorders such as major depressive disorder (MDD) and bipolar disorder, both central and peripheral BDNF levels are often reduced, reflecting impaired synaptic remodelling and neurogenesis, particularly in hippocampal and prefrontal circuits. Genetic variants and epigenetic modifications of the BDNF gene can influence its expression and contribute to individual differences in vulnerability, symptom severity and treatment response. Peripheral measurements of BDNF, typically from serum or plasma, offer a window into central neurotrophic activity, although methodological heterogeneity remains a challenge. Restoration of BDNF expression has been observed following successful pharmacological and non-pharmacological interventions, supporting the neurotrophic hypothesis of depression. Beyond symptom alleviation, enhancement of BDNF-driven plasticity may underpin resilience and cognitive recovery. Emerging work seeks to integrate molecular biomarkers, neuroimaging and clinical phenotypes to refine personalised therapeutic strategies, underscoring the global significance of BDNF as both a mechanistic target and potential biomarker in mood disorder management.

Research from Nature Portfolio

No recent Nature Portfolio content available.

BDNF Levels and Neuroplasticity in Mood Disorders publication trend

The graph below shows the total number of articles in bdnf levels and neuroplasticity in mood disorders across all publications each year (not limited to Nature Index journals).

Technical terms

BDNF: Brain-derived neurotrophic factor, a protein that promotes neuronal survival, growth and synaptic plasticity.

Neuroplasticity: The ability of the nervous system to reorganise structure and function in response to experience or injury.

proBDNF: The precursor form of BDNF that can have distinct, often opposing, effects to mature BDNF on neuronal function.

TrkB: Tropomyosin receptor kinase B, the principal receptor that mediates mature BDNF signalling.

Peripheral biomarker: A measurable indicator in accessible tissues (such as blood) reflecting central nervous system activity.

MDD: Major depressive disorder, a clinical condition characterised by persistent low mood, anhedonia and impaired cognitive function.

TRD: Treatment-resistant depression, a form of depressive illness that does not respond adequately to standard therapies.

References

  1. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses. Neuroscience & Biobehavioral Reviews (2023).
  2. Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review. International Journal of Molecular Sciences (2023).
  3. Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression. Biomolecules (2023).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.